New Trends in Urologic Oncology: Surgical Treatments, Robotics, Biomarkers, Diagnostic Tools, and Innovative Therapies

Dear Colleagues,

Urologic oncology is undergoing rapid development, with significant progress across surgical, diagnostic, and therapeutic domains. This Special Issue, “New Trends in Urologic Oncology: Surgical Treatments, Robotics, Biomarkers, Diagnostic Tools, and Innovative Therapies”, will provide an overview of the most recent advances shaping the management of genitourinary malignancies. Particular attention will be given to the evolution of minimally invasive and robotic-assisted techniques, the refinement of surgical outcomes, and the integration of novel systemic and targeted treatment strategies.

In parallel, the identification and clinical implementation of biomarkers, together with advances in molecular and imaging-based diagnostics, are enabling earlier detection, more precise risk stratification, and individualized therapeutic approaches. These developments are progressively moving the field toward a model of precision oncology, in which treatment decisions are informed by both technological innovation and molecular characterization.

We welcome contributions in the form of original research articles, reviews, and clinical studies that reflect these advances and will help in defining new standards of care.

Dr. Alessandro Uleri
Dr. Roberto Contieri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.